Business
BIOEX: Sales growth and improved margins signal progress in Bioextrax's commercialization
BIOEX: Sales growth and improved margins signal progress in Bioextrax's commercialization
About this update from Bioextrax Ab
Net sales increased to 79 tkr in Q1 2025, with operating losses narrowing and key customer projects advancing toward commercialization. Liquidity is secured for the next 12 months following a rights issue. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.